Literature DB >> 10411473

Potentiation of cADPR-induced Ca(2+)-release by methylxanthine analogues.

R A Cavallaro1, L Filocamo, A Galuppi, A Galione, M Brufani, A A Genazzani.   

Abstract

Caffeine and other methylxanthines are known to induce Ca(2+)-release from intracellular stores via the ryanodine receptor. In the present work, a range of caffeine analogues, in which methyl groups at the 1 and 7 positions were replaced with alkyl chains containing different functional groups (oxo, hydroxyl, propargyl, ester, and acids), were synthesized. These compounds were then screened for their ability to potentiate Ca(2+)-release induced by cADPR (an endogenous modulator of ryanodine receptors) in sea urchin egg homogenates. Two of the synthesized methylxanthines, 1, 3-dimethyl-7-(7-hydroxyoctyl)xanthine (37) and 3-methyl-7-(7-oxooctyl)-1-propargylxanthine (66), were shown to be more potent than caffeine in potentiating cADPR-induced Ca(2+)-release, while 1,3-dimethyl-7-(5-ethylcarboxypentyl)xanthine (14) was shown to be more efficacious. The development of new methylxanthine analogues may lead to a better understanding of ryanodine receptor function and could possibly provide novel therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411473     DOI: 10.1021/jm980469t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  An enantioselective synthesis of the core unit of the non-nucleoside reverse transcriptase inhibitor taurospongin A.

Authors:  Arun K Ghosh; Hui Lei
Journal:  Tetrahedron Asymmetry       Date:  2003-02-18

2.  Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors.

Authors:  Dan Shi; William L Padgett; John W Daly
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

3.  Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases.

Authors:  Alexander W Schüttelkopf; Ole A Andersen; Francesco V Rao; Matthew Allwood; Christina L Rush; Ian M Eggleston; Daan M F van Aalten
Journal:  ACS Med Chem Lett       Date:  2011-03-23       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.